These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21418783)

  • 1. Aspects of allergy in rheumatology.
    Spoerl D; Scherer K; Tyndall A
    Clin Exp Rheumatol; 2011; 29(3):560-6. PubMed ID: 21418783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desensitization to hydroxychloroquine: alternative interpretations.
    Sontheimer RD
    J Rheumatol; 2007 Feb; 34(2):253-5; discussion 255. PubMed ID: 17304648
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical immunotoxicity of antirheumatic drugs.
    Bálint G; Gergely P
    Inflamm Res; 1996 Dec; 45 Suppl 2():S91-5. PubMed ID: 8988409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive Rheumatology: Meeting Today's Challenges.
    Sammaritano LR; Chakravarty EF
    Rheum Dis Clin North Am; 2017 May; 43(2):xiii-xiv. PubMed ID: 28390572
    [No Abstract]   [Full Text] [Related]  

  • 5. Pediatric rheumatology for the adult rheumatologist.
    Wagner-Weiner L
    J Clin Rheumatol; 2008 Apr; 14(2):109-19. PubMed ID: 18391684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Allergic complications in patients with rheumatism].
    Anggelutsa PA; Brizinskiĭ MA; Ter-Vartan'ian SKh
    Vrach Delo; 1989 Sep; (9):9-12. PubMed ID: 2609633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheumatology. 3. Modern drug therapies and current guidelines in rheumatology nursing.
    Hill J; Reay N
    Nurs Times; 2002 Mar 7-13; 98(10):41-4. PubMed ID: 11921625
    [No Abstract]   [Full Text] [Related]  

  • 8. Refining drug safety in rheumatology.
    Cush JJ; Dao KH
    Rheum Dis Clin North Am; 2012 Nov; 38(4):xi-xiv. PubMed ID: 23137585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical Pearls About Current Rheumatic Medications.
    Ward IM; Knott A
    Prim Care; 2018 Jun; 45(2):193-212. PubMed ID: 29759120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geropharmacology for the rheumatologist.
    Percy LA; Fang MA
    Rheum Dis Clin North Am; 2000 Aug; 26(3):433-54, v-vi. PubMed ID: 10989506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biologics and cardiovascular risk].
    Tarner IH; Müller-Ladner U; Hamm C
    Z Rheumatol; 2010 Oct; 69(8):702-6, 708-11. PubMed ID: 20862482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitivity reactions to biologics used in rheumatology.
    Matucci A; Nencini F; Maggi E; Vultaggio A
    Expert Rev Clin Immunol; 2019 Dec; 15(12):1263-1271. PubMed ID: 31639316
    [No Abstract]   [Full Text] [Related]  

  • 13. [Individual and interdisciplinary treatment of rheumatic diseases in pregnancy].
    Bolz M
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2415. PubMed ID: 18988135
    [No Abstract]   [Full Text] [Related]  

  • 14. Desensitization to hydroxychloroquine--experience of 4 patients.
    Mates M; Zevin S; Breuer GS; Navon P; Nesher G
    J Rheumatol; 2006 Apr; 33(4):814-6. PubMed ID: 16463436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Off-label therapy in rheumatology].
    Krüger K; Sieper J
    Z Rheumatol; 2012 Feb; 71(2):99-100. PubMed ID: 22370799
    [No Abstract]   [Full Text] [Related]  

  • 16. 'Life cycle in modern rheumatology' matters: new drugs require new therapeutic strategies and innovative diagnostics.
    Dörner T; Burmester GR
    Curr Opin Rheumatol; 2008 May; 20(3):237-8. PubMed ID: 18388511
    [No Abstract]   [Full Text] [Related]  

  • 17. Rheumatic Disease Clinics of North America. Drug safety: managing innovation in rheumatology. Foreword.
    Weisman MH
    Rheum Dis Clin North Am; 2012 Nov; 38(4):ix-x. PubMed ID: 23137584
    [No Abstract]   [Full Text] [Related]  

  • 18. Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies.
    Woodworth TG; Furst DE; Strand V; Kempeni J; Fenner H; Lau CS; Miller F; Day R; Lipani J; Brooks P
    J Rheumatol; 2001 May; 28(5):1163-9. PubMed ID: 11361207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics/pharmacogenomics and antirheumatic drugs in rheumatology.
    Ferraccioli G; De Santis M; Tolusso B
    Pharmacogenomics; 2004 Dec; 5(8):1107-16. PubMed ID: 15584877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Individual prognosis of drug allergy complications in children with rheumatism].
    Khabizhanov BKh
    Vopr Revm; 1981; (1):23-6. PubMed ID: 6971525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.